Properties
Description
CTS-1027 inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases.
Molecular Formula
C19H20ClNO6S
Identity
Confirmed by NMR/HPLC/MS.
Applications
CTS-1027 is used to study the effects of inhibiting matrix metalloproteinases, relevant in tumor growth and metastasis research.